Candel Therapeutics Inc (NASDAQ:CADL) told investors on Thursday it has priced its previously disclosed public offering of about 18.3 million shares at $5.45 per share. The clinical-stage ...

To learn more, join Robinhood Markets CEO Vlad Tenev, Robinhood Markets CFO Shiv Verma, and Robinhood Ventures Fund I (RVI) President Sarah Pinto today, Feb. 17 at 10 a.m. PT / 1 p.m. ET for a ...

The offering was led by one of the Company's largest stockholders and several new institutional investors HESPERIA, CA ...

Gladstone Investment Corporation (Nasdaq:GAIN) (the "Company") today announced that it priced a public offering of $100.0 ...

Portland General Electric launched a public offering of $480M of common shares, after announcing a deal for PacifiCorp's wind ...

Private markets now offer digital discovery and education similar to public markets, making investments more accessible to advisors ...

Liminatus Pharma is a pre-clinical stage immuno-oncology company pioneering next-generation therapeutics, including its proprietary CD47-blockade antibody IBA101, designed to overcome the limitations ...

NUBURU, Inc. (NYSE American: BURU), a dual-use Defense & Security platform company, today announced the closing of its previously announced public offering and that it anticipates trading on NYSE ...

Nuburu said the offering comprises around 58.4 million common shares and 50.7 million pre-funded warrants, priced at $0.11 per share and $0.1099 per warrant. ・The company said gross proceeds will be ...

Pursuant to the Private Placement, Allied issued an aggregate of 16,000,000 Units to Alberta Investment Management Corporation (AIMCo), on behalf of its clients. The Units issued under the Private ...